Quantcast Alvine Pharmaceuticals Seeking Participants for Phase 2 Patient-Reported Outcome Study | NFCA
Skip Navigation Links

Alvine Pharmaceuticals Seeking Participants for Phase 2 Patient-Reported Outcome Study

Share |


Adults with celiac disease needed for a research study!

The study center is testing a new automated phone survey to measure symptoms of celiac disease that can be used to test new treatments for celiac disease.

Researchers are looking for people with celiac disease to test the new survey while eating a food with or without a small amount of gluten.

Participants will take the survey every day for 8 weeks and will come to the study center 5 times during the study. Participants will be compensated for their time.

This study is being sponsored by Alvine Pharmaceuticals.

If you are interested in learning more, please contact:

Beth Israel Deaconess Medical Center
Boston, MA
Joshua Hansen

University of Colorado Denver
Aurora, CO
Brittany Siller (Study Coordinator)

Just added!

Thomas Jefferson University Hospital
Philadelphia, PA
Angela Gordon (Study Coordinator)

Cleveland Clinic Digestive Disease Unit
Cleveland, OH
Louise Kincade (Study Coordinator)

Celiac Disease Center at Columbia University
New York, NY
Maria Teresa Minaya (Study Coordinator)


Stay tuned - More study centers will be added soon.

Note: NFCA maintains the position that views and information presented on articles and websites we link to are those of the authors, and not necessarily those of NFCA.

<< Back to Research News


  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter